Effectiveness of Shared Care Diabetes Management in Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
About this trial
This is an interventional supportive care trial for Type 2 Diabetes Mellitus focused on measuring Type 2 Diabetes, Diabetes Education and Management
Eligibility Criteria
Inclusion Criteria:
- Patients diagnosed with T2DM
- Patients who have Informed and signed the consent form content
- Patients can be regularly followed (every 3 months) for at least 3 years
Exclusion Criteria:
- Patients with important organ failure or other severe diseases including infection, mentally disorder, heart failure or disseminated intravascular coagulation
- Patients with active or inactive malignant tumour, expectation of life less than 1 year
- Patients with communication disorders, cannot communicate and/or cooperate
- Females that are regnant, breast-feeding female, or conception plan in the recent year
Sites / Locations
- Beijing Chao-Yang Hospital, Capital Medical University
Arms of the Study
Arm 1
Arm 2
No Intervention
Active Comparator
Traditional therapy group
Shared Care group
All patients in this group will be given routine diabetes management, including lifestyle education, health guidance, monitoring blood sugar guidance and drug adjustment.
The patients download the Shared Care mobile application and connect with the smart-glucometer Bg1 to upload blood glucose dairy in real time. With patient's informed consent, his or her data from each visit will be collected and recorded for analysis. After the patient returns home from the clinic, they can communicate through the APP with online diabetes educators. According to protocol, online diabetes educators answer patients' questions, give suggestions on patients' diet and summarize patients' issues to physicians, who provide high level supervision.